Patents by Inventor John Harrison Heiligenstein

John Harrison Heiligenstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of conduct disorder
    Patent number: 6184222
    Abstract: Norepinephrine reuptake inhibitors are used to treat conduct disorder.
    Type: Grant
    Filed: September 17, 1998
    Date of Patent: February 6, 2001
    Assignee: Eli Lilly and Company
    Inventor: John Harrison Heiligenstein
  • Treatment of attention-deficit/hyperactivity disorder
    Patent number: 6046193
    Abstract: Reboxetine is used to treat attention-deficit/hyperactivity disorder.
    Type: Grant
    Filed: September 17, 1998
    Date of Patent: April 4, 2000
    Assignee: Eli Lilly and Company
    Inventor: John Harrison Heiligenstein
  • Treatment of oppositional defiant disorder
    Patent number: 6028070
    Abstract: Norepinephrine reuptake inhibitors are used to treat oppositional defiant disorder.
    Type: Grant
    Filed: September 17, 1998
    Date of Patent: February 22, 2000
    Assignee: Eli Lilly and Company
    Inventor: John Harrison Heiligenstein
  • Treatment of attention-deficit/hyperactivity disorder
    Patent number: 5696168
    Abstract: A group of propanamines, norepinephrine uptake inhibitors, are used to treat attention-deficit/hyperactivity disorder.
    Type: Grant
    Filed: July 16, 1996
    Date of Patent: December 9, 1997
    Assignee: Eli Lilly and Company
    Inventors: John Harrison Heiligenstein, Bennett Coleman Laguzza, Steven Marc Paul, Gary Dennis Tollefson